Unraveling the 10q AMD Risk Locus
揭开 10 季度 AMD 风险轨迹
基本信息
- 批准号:9762936
- 负责人:
- 金额:$ 49.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:10q10q26AffectAgeAge related macular degenerationAllelesBiochemicalBiopsyBlindnessCellsChromosomesChromosomes, Human, Pair 1Chromosomes, Human, Pair 10Clustered Regularly Interspaced Short Palindromic RepeatsComputer AnalysisComputer-Assisted Image AnalysisDNA Sequence AlterationDevelopmentDiagnostic ProcedureDiseaseEndothelial CellsEyeEye DevelopmentFunctional disorderGenesGeneticGenetic PolymorphismGenotypeGoalsHeritabilityHumanImageIndividualInsulin-Like Growth Factor ILifeMolecularMolecular AnalysisMolecular GeneticsMorphologyMutationPathogenesisPathway interactionsPatient imagingPatientsPhenotypePhotoreceptorsPhysiologicalPlayPopulationPrevalenceProtocols documentationPublishingRegulationResolutionRetinalRiskRoleSkinStem cellsSusceptibility GeneTestingTherapeutic InterventionTissuesUnited StatesVariantbaseclinical imagingcohortcomplement systemdisease mechanisms studyeffective therapygenetic associationgenetic manipulationgenetic risk factorgenome editinghigh riskinduced pluripotent stem cellinsightinterdisciplinary approachmaculanew therapeutic targetpatient populationpostnatalresearch studyretinal imagingrisk variantsocietal coststranscriptome
项目摘要
ABSTRACT
Age-related macular degeneration (AMD) is the most common cause of severe visual loss in the developed
world, affecting more than 10 million people in the United States alone. Approximately 1 in 3 people over the
age of 75 are affected to some degree. A significant fraction of this disease is genetic, with major genetic risk
factors on chromosomes 1 and 10.
In this study, we will take advantage of molecular genetics, state of the art computer-assisted image analysis,
large patient populations, well characterized donor eye tissue, induced pluripotent stem cells and CRISPR
based genome editing to determine the molecular basis of how variations in AMD loci increase risk of AMD.
These studies will provide new insight into the pathophysiologic mechanisms of AMD that will be valuable for
the development of more specific diagnostic methods and more effective therapies.
抽象的
与年龄相关的黄斑变性(AMD)是发达的严重视觉丧失的最常见原因
世界,仅在美国就会影响超过1000万人。大约三分之一的人
75岁的年龄在某种程度上受到影响。这种疾病的很大一部分是遗传的,具有重大遗传风险
染色体1和10的因素。
在这项研究中,我们将利用分子遗传学的优势,即最先进的计算机辅助图像分析,
大量的患者人群,表征良好的供体眼组织,诱导多能干细胞和CRISPR
基于基因组编辑,以确定AMD基因座变化如何增加AMD风险的分子基础。
这些研究将为AMD的病理生理机制提供新的见解,这将对
开发更具体的诊断方法和更有效的疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWIN M STONE其他文献
EDWIN M STONE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWIN M STONE', 18)}}的其他基金
CRISPR-Cas9 based treatment of dominant retinal degeneration
基于 CRISPR-Cas9 的显性视网膜变性治疗
- 批准号:
10380840 - 财政年份:2016
- 资助金额:
$ 49.58万 - 项目类别:
CRISPR-Cas9 based treatment of dominant retinal degeneration
基于 CRISPR-Cas9 的显性视网膜变性治疗
- 批准号:
9886365 - 财政年份:2016
- 资助金额:
$ 49.58万 - 项目类别:
CRISPR/Cas9-mediated correction of mutations that cause inherited retinal degenerations
CRISPR/Cas9介导的导致遗传性视网膜变性的突变的校正
- 批准号:
9238770 - 财政年份:2016
- 资助金额:
$ 49.58万 - 项目类别:
Fibulin-Associated Age-Related Macular Degeneration
纤维蛋白相关的年龄相关性黄斑变性
- 批准号:
7122350 - 财政年份:2005
- 资助金额:
$ 49.58万 - 项目类别:
Molecular Genetics of Age Related Macular Degeneration
年龄相关性黄斑变性的分子遗传学
- 批准号:
8486435 - 财政年份:2005
- 资助金额:
$ 49.58万 - 项目类别:
Fibulin-Associated Age-Related Macular Degeneration
纤维蛋白相关的年龄相关性黄斑变性
- 批准号:
6962041 - 财政年份:2005
- 资助金额:
$ 49.58万 - 项目类别:
Fibulin-Associated Age-Related Macular Degeneration
纤维蛋白相关的年龄相关性黄斑变性
- 批准号:
7490420 - 财政年份:2005
- 资助金额:
$ 49.58万 - 项目类别:
Molecular Genetics of Age Related Macular Degeneration
年龄相关性黄斑变性的分子遗传学
- 批准号:
8271410 - 财政年份:2005
- 资助金额:
$ 49.58万 - 项目类别:
Molecular Genetics of Age Related Macular Degeneration
年龄相关性黄斑变性的分子遗传学
- 批准号:
8136186 - 财政年份:2005
- 资助金额:
$ 49.58万 - 项目类别:
相似海外基金
Optimizing Models of Non-Coding Genetic Risk in Age-Related Macular Degeneration
年龄相关性黄斑变性非编码遗传风险模型的优化
- 批准号:
10343475 - 财政年份:2022
- 资助金额:
$ 49.58万 - 项目类别:
Optimizing Models of Non-Coding Genetic Risk in Age-Related Macular Degeneration
年龄相关性黄斑变性非编码遗传风险模型的优化
- 批准号:
10574620 - 财政年份:2022
- 资助金额:
$ 49.58万 - 项目类别:
A synthetic genomics approach for characterizing Age-Related Macular Degeneration-associated genetic variation
用于表征年龄相关性黄斑变性相关遗传变异的合成基因组学方法
- 批准号:
9889806 - 财政年份:2019
- 资助金额:
$ 49.58万 - 项目类别:
Mitochondrial DNA Variations and Susceptibility to Oxidative Injury in the RPE
RPE 中线粒体 DNA 变异和氧化损伤的易感性
- 批准号:
7530551 - 财政年份:2008
- 资助金额:
$ 49.58万 - 项目类别: